Nulla Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Nulla Bio General Information
Description
Provider of crop development research services intended to improve health and welfare. The company offers research work for crop precision breeding using genetic scissors, enabling businesses to produce sustainable crops and improve crop life.
Contact Information
Website
nullabio.comCorporate Office
- 27-305, 501 Jinju-daero
- Jinju, Gyeongsangnam 52828
- South Korea
Corporate Office
- 27-305, 501 Jinju-daero
- Jinju, Gyeongsangnam 52828
- South Korea
Nulla Bio Timeline
Nulla Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 02-Jun-2024 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Apr-2022 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Nulla Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nulla Bio Patents
Nulla Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260159848-A1 | Method for enhancing plant transformation efficiency by using agrobacterium carrying virg mutant gene and nahg gene | Pending | 10-Dec-2024 | ||
| WO-2026127248-A1 | Method for improving transformation efficiency of plants by using agrobacterium into which virg mutant gene and nahg gene have been introduced | Pending | 10-Dec-2024 | ||
| AU-2024383988-A1 | Method for increasing prime editing efficiency in plant | Pending | 21-Nov-2023 | ||
| EP-4814121-A1 | Method for increasing prime editing efficiency in plant | Pending | 21-Nov-2023 | ||
| WO-2025110750-A1 | Method for increasing prime editing efficiency in plant | Inactive | 21-Nov-2023 | C12N15/8205 |
Nulla Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nulla Bio Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ernest Ventures | Venture Capital | Minority | ||
| Honest Ventures | Venture Capital | Minority | ||
| Korea Technology Finance | Government | Minority |
Nulla Bio FAQs
-
When was Nulla Bio founded?
Nulla Bio was founded in 2022.
-
Where is Nulla Bio headquartered?
Nulla Bio is headquartered in Jinju, South Korea.
-
What is the size of Nulla Bio?
Nulla Bio has 4 total employees.
-
What industry is Nulla Bio in?
Nulla Bio’s primary industry is Other Commercial Services.
-
Is Nulla Bio a private or public company?
Nulla Bio is a Private company.
-
What is Nulla Bio’s current revenue?
The current revenue for Nulla Bio is .
-
How much funding has Nulla Bio raised over time?
Nulla Bio has raised $287K.
-
Who are Nulla Bio’s investors?
Ernest Ventures, Honest Ventures, and Korea Technology Finance have invested in Nulla Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
